In recent years,the etiology of portal hypertension has undergone many changes.In addition to the focus on viral and alcoholic liver diseases,obesity,hyperlipidemia and diabetes patients,all kinds of drugs,especially after chemotherapy with platinum drugs,bone marrow proliferative diseases,autoimmune liver disease patients,need to be included in the high-risk screening population.The change in etiology brings about complex pathological and physiological states.We need to conduct a comprehensive evaluation,understand past medical history,improve portal vein computed tomography(CT),liver elastography,gastroscopy and other examinations,clarify the etiology,and choose personalized treatment plans for patients.Through technological innovation,we aim to improve the efficacy of endoscopic therapy,combined with new concepts such as artificial intelligence,big data,and multi omics,so as to obtain more accurate prediction of portal vein pressure and clinical characteristics,refine risk stratification,and make more accurate personalized decisions for clinical diagnosis and treatment.
Hypertension,portalEsophageal and gastric varicesEndoscopy
NETL
NSTL
万方数据
